Invention Grant
- Patent Title: Neuromuscular junction
-
Application No.: US16492906Application Date: 2018-03-14
-
Publication No.: US11767513B2Publication Date: 2023-09-26
- Inventor: Dhruv Sareen , Berhan Mandefro , Anjoscha Kaus
- Applicant: CEDARS-SINAI MEDICAL CENTER
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Nixon Peabody LLP
- International Application: PCT/US2018/022511 2018.03.14
- International Announcement: WO2018/170180A 2018.09.20
- Date entered country: 2019-09-10
- Main IPC: C12N5/077
- IPC: C12N5/077 ; C12N5/074 ; C12N5/073 ; C12N5/00 ; C12N5/071 ; C12N5/0793

Abstract:
The invention relates to culturing motor neuron cells together with skeletal muscle cells in a fluidic device under conditions whereby the interaction of these cells mimic the structure and function of the neuromuscular junction (NMJ) providing a NMJ-on-chip. Good viability, formation of myo-fibers and function of skeletal muscle cells on fluidic chips allow for measurements of muscle cell contractions. Embodiments of motor neurons co-cultures with contractile myo-fibers are contemplated for use with modeling diseases affecting NMJ's, e.g. Amyotrophic lateral sclerosis (ALS).
Public/Granted literature
- US20200071673A1 NEUROMUSCULAR JUNCTION Public/Granted day:2020-03-05
Information query